» Articles » PMID: 35381428

Muscle Strength Gain is Positively Associated with Functional Recovery in Patients with Sarcopenic Obesity After Stroke

Overview
Date 2022 Apr 5
PMID 35381428
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Evidence regarding the effect of sarcopenic obesity on recovery in stroke patients is scarce in rehabilitation medicine. The aim of this study was to examine the association between changes in muscle strength and functional outcomes in patients with sarcopenic obesity undergoing rehabilitation after stroke.

Materials And Methods: This study was a retrospective cohort study of stroke patients, consecutively admitted to post-acute rehabilitation wards of a single hospital, of which, only those diagnosed with sarcopenic obesity at admission were included in the final analysis. Bioimpedance analysis was used to measure skeletal muscle mass and body fat mass. Sarcopenic obesity was defined as the presence of both sarcopenia and obesity. Sarcopenia was diagnosed using muscle mass index and handgrip strength. Obesity was diagnosed using body fat percentage (men ≥30%, women ≥35%). The evaluated outcomes were Functional Independence Measure (FIM)-motor score at discharge and its gain. Multiple regression analysis was used to verify whether changes in hand grip strength during hospitalization were associated with functional outcomes.

Results: Sixty-two patients (29 men) with a mean age of 78 years, were analyzed. The mean change in the hand grip strength was 3.9 kg. In multiple regression analysis, changes in the hand grip strength were significantly associated with FIM-motor at discharge (β = 0.34, P < 0.01) and FIM-motor gain (β = 0.58, P < 0.01).

Conclusions: Muscle strength gain was associated with improved functional recovery in stroke patients with sarcopenic obesity.

Citing Articles

Concurrent Negative Impact of Undernutrition and Heart Failure on Functional and Cognitive Recovery in Hip Fracture Patients.

Kamijikkoku S, Yoshimura Y Nutrients. 2023; 15(22).

PMID: 38004194 PMC: 10674784. DOI: 10.3390/nu15224800.


Polypharmacy and Its Association with Dysphagia and Malnutrition among Stroke Patients with Sarcopenia.

Matsumoto A, Yoshimura Y, Nagano F, Bise T, Kido Y, Shimazu S Nutrients. 2022; 14(20).

PMID: 36296943 PMC: 9609259. DOI: 10.3390/nu14204251.


The Applicability of the ESPEN and EASO-Defined Diagnostic Criteria for Sarcopenic Obesity in Japanese Patients after Stroke: Prevalence and Association with Outcomes.

Yoshimura Y, Wakabayashi H, Nagano F, Matsumoto A, Shimazu S, Shiraishi A Nutrients. 2022; 14(19).

PMID: 36235857 PMC: 9570818. DOI: 10.3390/nu14194205.


Potentially inappropriate medications are negatively associated with functional recovery in patients with sarcopenia after stroke.

Matsumoto A, Yoshimura Y, Nagano F, Shimazu S, Shiraishi A, Kido Y Aging Clin Exp Res. 2022; 34(11):2845-2855.

PMID: 36038811 DOI: 10.1007/s40520-022-02224-7.